Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VLP-N-00033
| Cat. No. | VLP-N-00033 |
| Description | Virus-Like Particles that contain structurally intact Human SSTR2 protein, designed for antibody screening and ligand binding assays etc. |
| Gene Abbr | SSTR2 |
| Gene Name | SSTR2 somatostatin receptor 2 [ Homo sapiens ] |
| Applications | Human SSTR2 (somatostatin receptor type 2) virus-like particles (VLPs) have a variety of potential applications in biotechnology, medical research, and therapeutics. Here are some key applications: Vaccine development: VLPs can be used to develop vaccines because they can elicit a strong immune response and do not contain disease-causing genetic material. They are structurally similar to viruses, which makes them excellent candidates for presenting antigens to the immune system. Cancer research and treatment: SSTR2 is often overexpressed in certain types of tumors, such as neuroendocrine tumors. VLPs displaying SSTR2 can be used for targeted drug delivery, ensuring that therapeutics are specifically targeted to tumor cells that express the receptor. This can minimize damage to healthy cells and increase the effectiveness of cancer treatments. Immune system modulation: VLPs can act as adjuvants or immunomodulators. By displaying SSTR2, VLPs can be used to modulate immune responses and may play a role in treating immune-related diseases or enhancing immune responses to certain diseases. Drug screening: These particles can be used as a tool for high-throughput screening assays to identify new drugs that interact with the SSTR2 receptor. This is particularly useful in the early stages of drug discovery. Somatostatin Pathway Research: SSTR2 is part of the somatostatin receptor family and plays a role in regulating the endocrine system and inhibiting the release of various secondary hormones. VLPs can be used for research to understand the broader somatostatin signaling pathway and its significance in physiology and disease. |
| Storage | -80˚C |
| Shipping | Dry ice |
| Gene Name | SSTR2 somatostatin receptor 2 [ Homo sapiens ] |
| Gene Symbol | SSTR2 |
| Gene Description | somatostatin receptor 2 |
| Gene ID | 6752 |
| Uni Prot ID | P30874 |
| m RNA Refseq | NM_001050.2 |
| Protein Refseq | NP_001041.1 |
| Chromosome Location | 17q24 |
| Function | PDZ domain binding; protein binding; somatostatin receptor activity; |
| Pathway | Class A/1 (Rhodopsin-like receptors), organism-specific biosystem; G alpha (i) signalling events, organism-specific biosystem; GPCR downstream signaling, organism-specific biosystem; GPCR ligand binding, organism-specific biosystem; GPCRs, Class A Rhodopsin-like, organism-specific biosystem; GPCRs, Other, organism-specific biosystem; Gastric acid secretion, organism-specific biosystem; |
| MIM | 182452 |
Somatostatin receptor 2 (SSTR2) is one of the five known somatostatin receptor subtypes. These receptors are G protein-coupled receptors (GPCRs) that belong to the seven-transmembrane domain receptor superfamily. SSTR2 has been extensively studied for its roles in both normal and pathological conditions. In normal physiology, it helps maintain homeostasis by regulating the secretion of growth hormone, insulin, glucagon, and gastrointestinal peptides such as gastrin and cholecystokinin. It also has a role in inhibiting cell proliferation, which is critical for its role in controlling tumor growth and progression. SSTR2 is particularly important in neuroendocrine tumors because it is often overexpressed.
An innovative approach to studying and exploiting SSTR2 is the use of virus-like particles (VLPs), which present structurally intact human SSTR2 proteins on their surface. These VLPs are powerful objects for researchers to study the mechanisms of receptor function as well as potential therapeutic applications. Virus-like particles are nanoscale particles that mimic the organization and conformation of viruses but lack viral genetic material and are therefore not infectious. VLPs can be designed to display complex proteins in their native conformation, which is particularly valuable for proteins that span the cell membrane and exhibit complex tertiary structure, such as SSTR2. By incorporating a structurally intact SSTR2 into a VLP, the functionality of the receptor can be maintained while providing a powerful platform for biochemical and pharmacological studies.
A: SSTR2 (Somatostatin Receptor 2) is a Protein Coding gene. Diseases associated with SSTR2 include Neuroendocrine Tumor and Growth Hormone Secreting Pituitary Adenoma. Among its related pathways are Class A/1 (Rhodopsin-like receptors) and GPCR downstream signalling. Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and neuropeptide binding.
A: Centrifuge the vial prior to opening! Most of our products are lyophilized with a low concentration buffer, so the few micrograms of product may not be very visible. We recommend centrifuging the vial in a micro-centrifuge for 20-30 seconds before opening to drive any protein that may be lodged in the cap or on the side of the tube to the bottom of the vial. Our quality control procedures assure that each vial contains the correct amount of product.
A: Human SSTR2 VLPs are primarily used in research and development activities related to the study of SSTR2 and its interaction with various compounds or targeted therapies. These VLPs serve as excellent tools for testing the effectiveness of drug candidates, evaluating immune responses, and conducting immunization studies.
A: Human SSTR2 VLPs offer several advantages for research purposes. They provide a highly stable and consistent platform to study SSTR2 receptor interactions, allowing for more accurate and reproducible results. Additionally, the use of VLPs eliminates the need for working with infectious viruses, minimizing any associated risks involved in handling live viruses. These particles also offer potential applications in vaccine development and immunotherapy for diseases related to SSTR2, such as neuroendocrine tumors.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
I obtained Human SSTR2 Virus-Like Particles with excellent quality and purity from Creative Biogene for the ligand binding assay and obtained good results.
I purchased this product for antibody screening and Human SSTR2 Virus-Like Particles has good bioactivity and has greatly accelerated my experimental project.
I have been using the Human SSTR2 Virus-Like Particles for a while now, and they have exceeded my expectations. The ease of use and reliable performance have made them an invaluable tool in our lab. We have achieved consistent transduction efficiency and highly reproducible results.
The product is competitively priced, making it an affordable option without compromising on quality. I am thoroughly satisfied with this purchase and would recommend it to fellow researchers in the field.
The Human SSTR2 Virus-Like Particles product has revolutionized our studies on somatostatin receptors. The particles are of superior quality, ensuring consistent results for our experiments.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.